The archive
Every finding, one permanent page each, by day.
How strong the evidence is
A is a large trial or review, D is laboratory work only. "No results yet" is a registration or announcement that has not reported. What the grades mean.
What the findings are about
Every finding is filed into exactly one lane.
Findings per sweep
How much each day's run brought in. A flat day usually means the sources were quiet, not that the run failed.
Sources that have produced nothing
Watched, reachable, and yet nothing from them has ever reached the archive. Listed because a watchlist you cannot audit is a watchlist you cannot trust.
- NIH RePORTER, new kidney grants
- YouTube, NephJC / Freely Filtered
- YouTube, Dr Joe Dispenza
- YouTube — National Kidney Foundation
- YouTube — Dr. Joe Dispenza
- YouTube — NephJC / Freely Filtered
Sources whose work is not individually credited
These are read through Forager, and until 22 August every item fetched that way was filed simply as "Forager". They have contributed 68 published findings between them; we cannot yet say which came from which. Runs from now on record the originating source.
- JASN (page, needs Forager)
- CJASN (page, needs Forager)
- KDIGO guideline updates
- NKF newsroom
- FDA drug news (renal-filtered downstream)
- NIDDK news
- Kidney Precision Medicine Project
- UCSF Kidney Project (implantable bioartificial)
and 12 more.
Counted from the published pages themselves, so this cannot drift from what is in the archive. Updated 2026-09-10 03:17.
By day
2026-09-09
Nothing solid landed today, just an early lab idea about safer blood thinners
Today was a quiet day for kidney research. One preprint review came through, looking at a new class of blood thinner designed to cut clotting without...
2026-09-08
Two large record studies looked at common kidney drugs, but neither settles anything yet
Today's batch was about drug combinations for kidney disease that comes from type 2 diabetes. Both studies earned a C grade because they reviewed past...
2026-09-07
Fatty liver disease is linked to higher chances of kidney problems and other health issues
Today's findings focus on how fatty liver disease connects to other health problems, including kidney disease. One large snapshot study showed a link...
2026-09-06
Big swings in blood potassium levels linked to higher death risk for people on dialysis
Researchers followed 201 people on dialysis for about 6 years and found that unstable potassium levels — measured as K-CV — were associated with...
2026-09-05
A rare non-cancer condition mimicking throat cancer was reported in one man with advanced kidney disease
Today's report described a single case of malakoplakia in the throat and voice box of a man with both diabetes and advanced kidney disease. The...
2026-09-04
A quiet research day, with one study on pregnancy and inherited kidney cysts
Today brought no strong new results for people living with stage 3 kidney disease. The one original study covered pregnancy outcomes in polycystic...
2026-09-03
A pig kidney helped one person wait for a human donor, and new research looks at herbal capsules, games for kids, and diabetes trends
Today’s top story is a first-in-human case where a pig kidney supported a patient until a human donor kidney became available. Researchers also pooled...
2026-09-01
No new human studies today, just early lab work worth watching
Today's sweep turned up no studies in people, so there is nothing here that should change your care plan or your questions for your next appointment....
2026-08-31
Some common drugs may help protect kidneys in specific situations, but more research is needed
Today's findings focus on how existing medications—especially SGLT2 inhibitors—might influence kidney outcomes in special cases, though most evidence...
2026-08-30
A 12-week home exercise program helped stage 4-5 kidney patients walk farther and lowered muscle loss risk
Today's news centers on a small but encouraging study showing that structured home exercise, guided remotely, can improve physical function in...
2026-08-29
A large review found cholesterol drugs did not lower death rates in dialysis patients with heart artery disease
Today's findings focused on observational studies and reviews, not new trials. A large review found no benefit of statins for survival in dialysis...
2026-08-28
New research links diet, diabetes drugs, and mouth bacteria to kidney health—but none change daily care yet
Today's research updates focus on understanding links between kidney disease and other factors like diet, diabetes, and oral health. No new treatment...
2026-08-27
A new drug shows promise for a rare immune disease that attacks the kidneys, but more proof is needed
Today’s research focused on hospital-based and lab studies, not everyday kidney protection strategies. One real-world study looked at avacopan for a...
2026-08-26
A new review confirms SGLT2 inhibitors help older adults with heart failure, and a stent choice affects transplant recovery
Today’s findings focus on two strong, practice-relevant topics: SGLT2 inhibitors for heart and kidney protection in older adults, and stent choice...
2026-08-22
No new treatment results today — only links between heart, thyroid, and kidney health
Today brought no new clinical trial results for kidney disease treatments. Instead, two observational studies explored connections between heart...
2026-08-21
Several studies link heart health, diet, and other conditions to kidney changes — but none prove treatments work yet
Today’s research sweep found ten new studies, all observational or conceptual — none reported clinical trial results. Most explored how heart health,...
2026-08-20
Rising use of GLP-1 and SGLT2 drugs may slow kidney disease progression
GLP-1 and SGLT2 drugs are increasingly used to slow kidney disease decline. Bisphosphonates may prevent bone loss but carry risks of multiple-organ...
2026-08-19
GLP-1 drugs may protect heart and kidney health in type 2 diabetes
A large review of trials suggests GLP-1 drugs may protect heart and kidney health in people with type 2 diabetes. A potassium-lowering drug might help...
2026-08-18
SGLT2 inhibitors and GLP-1 agonists may slow kidney disease progression in diabetes patients
SGLT2 inhibitors or GLP-1 agonists could slow kidney disease progression in patients with diabetes and hypertension. Better surgical techniques for...
2026-08-17
Special olive oil may slow kidney decline in diabetes patients
A diabetes trial showed that olive oil with extra oleanolic acid could help preserve kidney function. Also, hospitalizations are a major reason...
2026-08-16
New studies on sepsis-related kidney injury and the role of social support in diet adherence
Today's research focuses on sepsis-related kidney injury and the social factors of diet adherence. No new studies were found on transplantation or...
2026-08-15
Small studies show mismatch in kidney function markers and sepsis risk
A small study found discrepancies in kidney function markers. A new model for sepsis-associated kidney injury risk was introduced.
2026-08-14
New findings on kidney injury risk and protein-energy wasting in dialysis patients
Today's research covers kidney injury risk prediction and HDL cholesterol function. No new results for diabetes, bone health, or cardiovascular...
2026-08-13
SGLT2 inhibitors may reduce muscle loss in patients with diabetes
SGLT2 inhibitors may reduce muscle loss in patients with diabetes. HDL function may influence cardiovascular health via protein levels. A protocol for...
2026-08-12
A strong research review looks at whether SGLT2 drugs can help polycystic kidney disease.
Today's main item is a research review that combined the results of many earlier studies to see if SGLT2 inhibitor drugs help people with polycystic...
2026-08-11
The most useful news for slowing early kidney disease: SGLT2 diabetes drugs helped protect kidney function, and blood pressure drugs called ACE...
2026-08-10
Kidney-protecting diabetes drugs are a big theme today: GLP-1 medicines (the Ozempic family) and SGLT2 inhibitors like dapagliflozin, which looked...